Surekha Tayade

Evaluation of Serum Nesfatin-1 Levels in Women with Polycystic Ovarian Syndrome and Estimating Its Correlation with Body Mass Index and Clinico-metabolic Profile

Nidhi Makhija & Surekha Tayade · Journal of Pharmaceutical Research International · 2021

Background: Polycystic ovarian syndrome (PCOS) is a diverse condition marked by irregular menstruation, hyperandrogenism, and recurrent anovulation. An incidence of 6% to 20% of PCOS in women of reproductive age has been reported. Nesfatin-1 is a potent anorexigenic peptide havin...

Open access Research Article 10.9734/jpri/2021/v33i63A35226

Polycystic Ovarian Syndrome: A Narrative Review Article on Serum Markers in Pcos

Shatakshi Arun Sharma & Surekha Tayade · Journal of Pharmaceutical Research International · 2021

PCOD is a heterogeneous illness characterized by clinically or biochemically excess androgen, dysfunction in ovulation, and polycystic ovaries that is caused by a complicated hereditary disease. Poly-cystic ovary syndrome (PCOS), affecting 10 to 20% of premenopausal females, is a...

Open access Research Article 10.9734/jpri/2021/v33i61B35882

Leptospirosis in COVID-19 Positive Pregnancy: A Rare Case Report Mimicking Hellp Syndrome

Aarshika Singh, Surekha Tayade, Ooha Thadiboina & Cherukuri Srinidhi · Journal of Pharmaceutical Research International · 2021

Leptospirosis in pregnancy is often underdiagnosed and not commonly reported due to its unusual appearance and rarity. It looks like HELLP syndrome, obstetric cholestasis, viral hepatitis & pregnancy-related acute fatty liver. Miscarriages in the first trimester, stillbirths,...

Open access Research Article 10.9734/jpri/2021/v33i43B32567